
Melody M. Burch
Examiner (ID: 12874, Phone: (571)272-7114 , Office: P/3657 )
| Most Active Art Unit | 3657 |
| Art Unit(s) | 3683, 3657, 3616, 3613 |
| Total Applications | 1593 |
| Issued Applications | 935 |
| Pending Applications | 131 |
| Abandoned Applications | 553 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9427121
[patent_doc_number] => 08703192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Dosage form containing pantoprazole as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/385280
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10333
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12385280
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385280 | Dosage form containing pantoprazole as active ingredient | Apr 2, 2009 | Issued |
Array
(
[id] => 6252408
[patent_doc_number] => 20100028427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'IMMEDIATE RELEASE FORMULATIONS OF 1-AMINOCYCLOHEXANE COMPOUNDS, MEMANTINE AND NERAMEXANE'
[patent_app_type] => utility
[patent_app_number] => 12/410224
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13789
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028427.pdf
[firstpage_image] =>[orig_patent_app_number] => 12410224
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410224 | IMMEDIATE RELEASE FORMULATIONS OF 1-AMINOCYCLOHEXANE COMPOUNDS, MEMANTINE AND NERAMEXANE | Mar 23, 2009 | Abandoned |
Array
(
[id] => 6024230
[patent_doc_number] => 20110052556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND CARNITINE AND PROCESS FOR ITS PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/919938
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6740
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919938
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919938 | PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND CARNITINE AND PROCESS FOR ITS PREPARATION | Feb 26, 2009 | Abandoned |
Array
(
[id] => 11634029
[patent_doc_number] => 09655983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Process for preparing a pharmaceutical formulation of contrast agents'
[patent_app_type] => utility
[patent_app_number] => 12/918259
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10529
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918259
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918259 | Process for preparing a pharmaceutical formulation of contrast agents | Feb 17, 2009 | Issued |
Array
(
[id] => 6046930
[patent_doc_number] => 20110206770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 MICRONS TO ABOUT 10 MICRONS'
[patent_app_type] => utility
[patent_app_number] => 13/054888
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5417
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206770.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054888
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054888 | ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 MICRONS TO ABOUT 10 MICRONS | Feb 3, 2009 | Abandoned |
Array
(
[id] => 5545476
[patent_doc_number] => 20090155353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'MICROEMULSIONS FOR PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/364875
[patent_app_country] => US
[patent_app_date] => 2009-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4242
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155353.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364875 | MICROEMULSIONS FOR PHARMACEUTICAL COMPOSITIONS | Feb 2, 2009 | Abandoned |
Array
(
[id] => 5379293
[patent_doc_number] => 20090191132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Coded medication and methods of preparing same for identification and distinguishment'
[patent_app_type] => utility
[patent_app_number] => 12/322021
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5892
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191132.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322021
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322021 | Coded medication and methods of preparing same for identification and distinguishment | Jan 27, 2009 | Abandoned |
Array
(
[id] => 7668998
[patent_doc_number] => 20110318267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'PH-RESPONSIVE NANOSTRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 12/864265
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20255
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12864265
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864265 | PH-RESPONSIVE NANOSTRUCTURES | Jan 22, 2009 | Abandoned |
Array
(
[id] => 6474694
[patent_doc_number] => 20100284924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'NANO-DEVICES HAVING IMPELLERS FOR CAPTURE AND RELEASE OF MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/812359
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9227
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0284/20100284924.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812359 | NANO-DEVICES HAVING IMPELLERS FOR CAPTURE AND RELEASE OF MOLECULES | Jan 22, 2009 | Abandoned |
Array
(
[id] => 5342300
[patent_doc_number] => 20090180950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Polychromatic, diversely-sized particles for angiography'
[patent_app_type] => utility
[patent_app_number] => 12/319369
[patent_app_country] => US
[patent_app_date] => 2009-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9412
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20090180950.pdf
[firstpage_image] =>[orig_patent_app_number] => 12319369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319369 | Polychromatic, diversely-sized particles for angiography | Jan 5, 2009 | Abandoned |
Array
(
[id] => 5436611
[patent_doc_number] => 20090171198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Powdered marker'
[patent_app_type] => utility
[patent_app_number] => 12/317339
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3596
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20090171198.pdf
[firstpage_image] =>[orig_patent_app_number] => 12317339
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/317339 | Powdered marker | Dec 18, 2008 | Abandoned |
Array
(
[id] => 5509200
[patent_doc_number] => 20090082407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Pyridoxamine for the Treatment of Diabetic Kidney Disease'
[patent_app_type] => utility
[patent_app_number] => 12/325818
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4048
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325818
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325818 | Pyridoxamine for the Treatment of Diabetic Kidney Disease | Nov 30, 2008 | Abandoned |
Array
(
[id] => 5576400
[patent_doc_number] => 20090143762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Methods and Compositions for Enhancing the Viability Of Microneedle Pores'
[patent_app_type] => utility
[patent_app_number] => 12/325919
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10674
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143762.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325919
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325919 | Methods and Compositions for Enhancing the Viability Of Microneedle Pores | Nov 30, 2008 | Abandoned |
Array
(
[id] => 6038338
[patent_doc_number] => 20110091387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCING SKIN DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 12/742804
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9264
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742804
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742804 | METHODS AND COMPOSITIONS FOR REDUCING SKIN DAMAGE | Nov 16, 2008 | Abandoned |
Array
(
[id] => 5514296
[patent_doc_number] => 20090214602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'ORAL DOSAGE FORMS INCLUDING AN ANTIPLATELET AGENT AND AN ENTERICALLY COATED ACID INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/254640
[patent_app_country] => US
[patent_app_date] => 2008-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30872
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214602.pdf
[firstpage_image] =>[orig_patent_app_number] => 12254640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/254640 | Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor | Oct 19, 2008 | Issued |
Array
(
[id] => 6263340
[patent_doc_number] => 20100297242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'LDL-LIKE CATIONIC NANOPARTICLES FOR DELIVERYING NUCLEIC ACID GENE, METHOD FOR PREPARING THEREOF AND METHOD FOR DELIVERYING NUCLEIC ACID GENE USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/682984
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7609
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682984
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682984 | LDL-LIKE CATIONIC NANOPARTICLES FOR DELIVERYING NUCLEIC ACID GENE, METHOD FOR PREPARING THEREOF AND METHOD FOR DELIVERYING NUCLEIC ACID GENE USING THE SAME | Oct 16, 2008 | Abandoned |
Array
(
[id] => 6391347
[patent_doc_number] => 20100303753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Oligomer Conjugates of Lidocaine and Its Derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/682778
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22107
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303753.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682778 | Oligomer Conjugates of Lidocaine and Its Derivatives | Oct 16, 2008 | Abandoned |
Array
(
[id] => 5428097
[patent_doc_number] => 20090087407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'METHODS FOR THE TREATMENT OF SCLERODERMA USING 1-OXO-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-METHYLISOINDOLINE'
[patent_app_type] => utility
[patent_app_number] => 12/249350
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21225
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12249350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/249350 | METHODS FOR THE TREATMENT OF SCLERODERMA USING 1-OXO-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-METHYLISOINDOLINE | Oct 9, 2008 | Abandoned |
Array
(
[id] => 6142264
[patent_doc_number] => 20110129504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'COMPOSITION FOR CONTROLLING LIPASE CATALYZED REACTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/681038
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5212
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129504.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681038 | COMPOSITION FOR CONTROLLING LIPASE CATALYZED REACTIONS | Sep 30, 2008 | Abandoned |
Array
(
[id] => 6617276
[patent_doc_number] => 20100003290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'OIL AND WATER REPELLENT COSMETIC POWDER AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/239788
[patent_app_country] => US
[patent_app_date] => 2008-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5000
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003290.pdf
[firstpage_image] =>[orig_patent_app_number] => 12239788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/239788 | OIL AND WATER REPELLENT COSMETIC POWDER AND METHODS OF MAKING AND USING SAME | Sep 27, 2008 | Abandoned |